Rural Health
News by Topic: Pharmacy and prescription drugs
Jan 17, 2025 - Notice of final rule from the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) authorizing the Department of Veterans Affairs (VA) healthcare practitioners acting within the scope of their VA employment to prescribe controlled substances via telemedicine to a VA patient with whom they have not conducted an in-person medical evaluation. VA practitioners can prescribe controlled substances to VA patients if another VA practitioner has previously conducted an in-person medical evaluation of the VA patient at any time, subject to certain conditions. This final rule is effective February 18, 2025.
Source: Federal Register
Jan 17, 2025 - Notice of final rule from the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) amending their regulations to increase access to buprenorphine treatment for opioid use disorders (OUD) through a telemedicine encounter. This rule expands the circumstances under which individual providers are authorized to prescribe buprenorphine for OUD via telemedicine, including an audio-only telemedicine encounter. This final rule is effective February 18, 2025.
Source: Federal Register
DEA: Special Registrations for Telemedicine and Limited State Telemedicine Registrations
Federal Register
Jan 17, 2025 - Notice of proposed rulemaking from the Drug Enforcement Administration (DEA) proposing regulatory changes aimed at expanding patient access to controlled substance medications via telemedicine while mitigating the risks of diversion associated with such expansion. Proposed changes would establish a Special Registration framework and authorize three types of Special Registration that would allow more comprehensive prescribing, including prescribing of Schedule II and narcotic and non-narcotic controlled substances in limited circumstances, by properly registered physicians and mid-level practitioners and dispensing by online telemedicine platforms that constitute covered online telemedicine platforms. Comments are due by March 18, 2025.
Source: Federal Register
Jan 15, 2025 - Announces a new grant to combat the opioid epidemic in rural Georgia by training, supporting, and compensating 50 rural pharmacists in dispensing naloxone in addition to community education regarding local resources. Describes increases in overdose deaths and the use of fentanyl in Georgia.
Source: UGA Today
EBSA, HHS, IRS: Enhancing Coverage of Preventive Services Under the Affordable Care Act
Federal Register
Jan 15, 2025 - Notice from the Employee Benefits Security Administration (EBSA), Internal Revenue Service (IRS), and Department of Health and Human Services (HHS) withdrawing the October 28, 2024, notice of proposed rulemaking regarding coverage of certain preventive services under the Patient Protection and Affordable Care Act, which requires non-grandfathered group health plans and non-grandfathered group or individual health insurance coverage to cover certain contraceptive services without cost sharing. This withdrawal is effective January 15, 2025.
Source: Federal Register
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Jan 3, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Advantage Model of Care Submission Requirements; and 2) Request for Termination of Medicare Premium Part A, Part B, or Part B Immunosuppressive Drug Coverage (Part B-ID) and Supporting Statute and Regulations. Comments are due by March 4, 2025.
Source: Federal Register
EBSA, HHS, IRS: Coverage of Certain Preventive Services Under the Affordable Care Act
Federal Register
Dec 30, 2024 - Notice from the Employee Benefits Security Administration (EBSA), Internal Revenue Service (IRS), and Department of Health and Human Services (HHS) withdrawing the February 2, 2023, notice of proposed rulemaking regarding coverage of certain preventive services under the Patient Protection and Affordable Care Act, which requires non-grandfathered group health plans and non-grandfathered group or individual health insurance coverage to cover certain contraceptive services without cost sharing. This withdrawal is effective December 23, 2024.
Source: Federal Register
Dec 13, 2024 - Notice of final rule from the U.S. Department of Health and Human Services (HHS) adopting updated versions of the retail pharmacy standards for electronic transactions adopted under the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). These updated versions are modifications to the currently adopted standards for the following retail pharmacy transactions: healthcare claims or equivalent encounter information; eligibility for a health plan; referral certification and authorization; and coordination of benefits. This final rule also adopts a modification to the standard for the Medicaid pharmacy subrogation transaction. This rule is effective February 11, 2025. Compliance with this rule is required by February 11, 2028.
Source: Federal Register
Dec 12, 2024 - Notice from the U.S. Department of Justice (DOJ) Drug Enforcement Administration (DEA) seeking comments on proposed recordkeeping regulations for emergency medical services (EMS) agencies that handle controlled substances. The Protecting Patient Access to Emergency Medications Act of 2017 amended the Controlled Substances Act to allow for a new registration category for emergency medical services agencies that handle controlled substances. Among other things, the proposed regulations would require an EMS agency to maintain records for each controlled substance administered or disposed of while providing emergency medical services. Comments are due by January 13, 2025.
Source: Federal Register
HHS: 12th Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19
Federal Register
Dec 11, 2024 - Notice of amendment from the Department of Health and Human Services extending the determination of a public health emergency and states that COVID-19 presents a credible risk of a future public health emergency. Among other things, this amendment extends liability immunity for licensed pharmacists, pharmacy interns, and qualified pharmacy technicians to prescribe, dispense, and administer COVID-19 vaccines, seasonal influenza vaccines, and COVID-19 tests through December 31, 2029. This amendment is effective January 1, 2025.
Source: Federal Register